Lyubov Remennik, Ph.D., M.D.

Program Manager


Dr. Lyubov Remennik is an oncologist with expertise in ontology development, cancer surveillance, epidemiology, public health and informatics support of clinical and population-based studies. At CBIIT, she leads and coordinates the Enterprise Vocabulary Services (EVS) for content development, editing, and production, including terminology services collaborations with the Clinical Trials Reporting Program (CTRP), Genomic Data Commons (GDC), external health agencies, and data standard organizations. Dr. Remennik previously worked at the NIH Clinical Center Biomedical Translational Research Information System (BTRIS) providing leadership in building semantic infrastructure, ontology development, and data standards implementation for the only NIH information system integrating longitudinal data across NIH institutions from more than 10,000 clinical studies, and serving multiple disparate information systems across diverse knowledge domains and data types.  Dr. Remennik earned her medical degree and doctorate in cancer immunology and virology in Russia. Her doctoral research was focused on the molecular epidemiology of antigens relative to the structural proteins of mouse mammary tumor virus (MMTV) in the human population. Dr. Remennik was a founding leader of the Russian national cancer surveillance system (aggregating cancer and healthcare data in a population of 145 million) and managed a portfolio of research projects with an emphasis on cancer incidence, mortality, screening, diagnosis, treatment and outcomes, adverse event reporting, clinical data collection and analysis, and public health. She served as a co-investigator for the World Health Organization large-scale prospective study on the assessment of the efficacy of breast self-examination in reducing breast cancer mortality and as a principal investigator for several WHO and International Agency for Research on Cancer (IARC) projects aimed at evaluating the consequences of the Chernobyl accident and nuclear missiles testing.